{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:20:49Z","timestamp":1776259249743,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Swedish Cancer Society","award":["24 3414"],"award-info":[{"award-number":["24 3414"]}]},{"name":"Stockholm County Council","award":["FoUI-985983"],"award-info":[{"award-number":["FoUI-985983"]}]},{"name":"Cancer Research Funds of Radiumhemmet","award":["231243"],"award-info":[{"award-number":["231243"]}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Most patients who undergo esophagectomy for esophageal cancer develop tumor recurrence and die within 5\u00a0years of surgery. An impact of preoperative dental status on survival in this patient group has been suggested but remains uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This national Swedish cohort study included 871 patients who underwent esophagectomy for esophageal cancer (adenocarcinoma or squamous cell carcinoma) between 2011 and 2020 and were followed up until 2024. The exposure was the number of remaining teeth, based on dentist visits within 5\u00a0years before the esophagectomy, categorized into five (quintiles) and 10 (deciles) groups. The main outcome was all-cause 5-year mortality. Data were retrieved from medical records and national complete registries. Multivariable Cox regression provided hazard ratios (HRs) with 95% confidence intervals (CIs), adjusted for age, sex, comorbidity, tumor histology, neoadjuvant therapy, education level, and pathological tumor stage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There were no statistically significant associations between the number of remaining teeth and the risk of all-cause 5-year mortality, independent of the categorization of the number of teeth. The HR was 1.13 (95% CI 0.85\u20131.51) comparing the lowest quintile of remaining teeth (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20090\u201319) with the highest quintile (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200929\u201332), and the HR was 0.98 (95% CI 0.64\u20131.52) comparing the lowest decile of remaining teeth (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20090\u201310) with the highest decile (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200931\u201332). There were no statistically significant associations in any of the subgroup analyses of age, comorbidity, or education.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study did not identify any association between the number of remaining teeth and the risk of 5\u00a0year mortality in patients who underwent esophagectomy for esophageal cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-026-19101-6","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T19:38:07Z","timestamp":1769629087000},"page":"4204-4211","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dental Health and Survival Following Surgery for Esophageal Cancer"],"prefix":"10.1245","volume":"33","author":[{"given":"Kenzo","family":"Buchli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eivind","family":"Gottlieb-Vedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrik","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellinor","family":"Wistr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Klinge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pernilla","family":"Lagergren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Lagergren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"issue":"3","key":"19101_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"19101_CR2","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1245\/s10434-025-17007-3","volume":"32","author":"E Lundberg","year":"2025","unstructured":"Lundberg E, Mattsson F, Gottlieb-Vedi E, et al. Time trends in survival after surgery for esophageal cancer in a National population-based study in Sweden. Ann Surg Oncol. 2025;32(5):3167\u201374.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"19101_CR3","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.athoracsur.2022.02.085","volume":"114","author":"AE Slaman","year":"2022","unstructured":"Slaman AE, Pirozzolo G, Eshuis WJ, et al. Improved clinical and survival outcomes after esophagectomy for cancer over 25 years. Ann Thorac Surg. 2022;114(4):1118\u201326.","journal-title":"Ann Thorac Surg"},{"issue":"9","key":"19101_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2023.04.004","volume":"49","author":"VEJ Sirvi\u00f6","year":"2023","unstructured":"Sirvi\u00f6 VEJ, R\u00e4s\u00e4nen JV, Kauppila JH. Time trends in mortality of oesophageal cancer in Finland over 30 years. Eur J Surg Oncol. 2023;49(9):106905.","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"19101_CR5","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1245\/s10434-020-09200-3","volume":"28","author":"SM Griffin","year":"2021","unstructured":"Griffin SM, Jones R, Kamarajah SK, et al. Evolution of esophagectomy for cancer over 30 Years: changes in presentation. Manage Outcomes Ann Surg Oncol. 2021;28(6):3011\u201322.","journal-title":"Manage Outcomes. Ann Surg Oncol"},{"issue":"5","key":"19101_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-021495","volume":"8","author":"JH Kauppila","year":"2018","unstructured":"Kauppila JH, Mattsson F, Brusselaers N, et al. Prognosis of oesophageal adenocarcinoma and squamous cell carcinoma following surgery and no surgery in a nationwide Swedish cohort study. BMJ Open. 2018;8(5):e021495.","journal-title":"BMJ Open"},{"issue":"11","key":"19101_CR7","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/S1470-2045(05)70347-8","volume":"6","author":"I Rouvelas","year":"2005","unstructured":"Rouvelas I, Zeng W, Lindblad M, et al. Survival after surgery for oesophageal cancer: a population-based study. Lancet Oncol. 2005;6(11):864\u201370.","journal-title":"Lancet Oncol"},{"issue":"3","key":"19101_CR8","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/00000658-200109000-00010","volume":"234","author":"JR Siewert","year":"2001","unstructured":"Siewert JR, Stein HJ, Feith M, et al. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1000 consecutive resections at a single center in the Western world. Ann Surg. 2001;234(3):360\u20137 (discussion 368-9).","journal-title":"Ann Surg"},{"issue":"7","key":"19101_CR9","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S1470-2045(11)70142-5","volume":"12","author":"KM Sjoquist","year":"2011","unstructured":"Sjoquist KM, Burmeister BH, Smithers BM, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011;12(7):681\u201392.","journal-title":"Lancet Oncol"},{"issue":"3","key":"19101_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0121928","volume":"10","author":"N Brusselaers","year":"2015","unstructured":"Brusselaers N, Mattsson F, Lindblad M, et al. Association between education level and prognosis after esophageal cancer surgery: a Swedish population-based cohort study. PLoS One. 2015;10(3):e0121928.","journal-title":"PLoS One"},{"issue":"2","key":"19101_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1177\/0022034511402080","volume":"23","author":"LJ Jin","year":"2011","unstructured":"Jin LJ, Armitage GC, Klinge B, et al. Global oral health inequalities: task group\u2013periodontal disease. Adv Dent Res. 2011;23(2):221\u20136.","journal-title":"Adv Dent Res"},{"key":"19101_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdent.2024.105304","volume":"149","author":"F Wang","year":"2024","unstructured":"Wang F, Li T, Han Q, et al. Associations of tooth loss with risk of all-cause and cause-specific mortality among US adults with diabetes mellitus. J Dent. 2024;149:105304.","journal-title":"J Dent"},{"issue":"1","key":"19101_CR13","doi-asserted-by":"publisher","first-page":"BSR20181773","DOI":"10.1042\/BSR20181773","volume":"39","author":"J Peng","year":"2019","unstructured":"Peng J, Song J, Han J, et al. The relationship between tooth loss and mortality from all causes, cardiovascular diseases, and coronary heart disease in the general population: systematic review and dose-response meta-analysis of prospective cohort studies. Biosci Rep. 2019;39(1):BSR20181773.","journal-title":"Biosci Rep."},{"key":"19101_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fmicb.2016.00053","volume":"7","author":"KY How","year":"2016","unstructured":"How KY, Song KP, Chan KG. Porphyromonas gingivalis: an overview of periodontopathic pathogen below the gum line. Front Microbiol. 2016;7:53.","journal-title":"Front Microbiol"},{"issue":"8","key":"19101_CR15","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000199","volume":"11","author":"S Peter","year":"2020","unstructured":"Peter S, Pendergraft A, VanDerPol W, et al. Mucosa-associated microbiota in barrett\u2019s esophagus, dysplasia, and esophageal adenocarcinoma differ similarly compared with healthy controls. Clin Transl Gastroenterol. 2020;11(8):e00199.","journal-title":"Clin Transl Gastroenterol"},{"issue":"1","key":"19101_CR16","doi-asserted-by":"publisher","first-page":"1563410","DOI":"10.1080\/20002297.2018.1563410","volume":"11","author":"I Olsen","year":"2019","unstructured":"Olsen I, Yilmaz \u00d6. Possible role of Porphyromonas gingivalis in orodigestive cancers. J Oral Microbiol. 2019;11(1):1563410.","journal-title":"J Oral Microbiol"},{"issue":"3","key":"19101_CR17","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1245\/s10434-019-07903-w","volume":"27","author":"S Miura","year":"2020","unstructured":"Miura S, Nakamura T, Hasegawa T, et al. Tooth loss predicts long-term prognosis of esophageal cancer after esophagectomy. Ann Surg Oncol. 2020;27(3):683\u201390.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"19101_CR18","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.21873\/invivo.13327","volume":"37","author":"H Tamagawa","year":"2023","unstructured":"Tamagawa H, Tamagawa A, Aoyama T, et al. Influence of the oral health assessment tool score on survival of patients with esophageal cancer. In Vivo. 2023;37(5):2253\u20139.","journal-title":"In Vivo"},{"issue":"13","key":"19101_CR19","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1200\/JCO.2015.65.2875","volume":"34","author":"SR Markar","year":"2016","unstructured":"Markar SR, Mackenzie H, Lagergren P, et al. Surgical proficiency gain and survival after esophagectomy for cancer. J Clin Oncol. 2016;34(13):1528\u201336.","journal-title":"J Clin Oncol"},{"issue":"4","key":"19101_CR20","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/01.sla.0000205825.34452.43","volume":"243","author":"M Lindblad","year":"2006","unstructured":"Lindblad M, Ye W, Lindgren A, et al. Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates. Ann Surg. 2006;243(4):479\u201385.","journal-title":"Ann Surg"},{"issue":"1","key":"19101_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3109\/0284186X.2011.633932","volume":"51","author":"K Lagergren","year":"2012","unstructured":"Lagergren K, Derogar M. Validation of oesophageal cancer surgery data in the swedish patient registry. Acta Oncol. 2012;51(1):65\u20138.","journal-title":"Acta Oncol"},{"key":"19101_CR22","unstructured":"Socialstyrelsen. Validering av uppgifter om kvarvarande och\u00a0intakta t\u00e4nder i Tandh\u00e4lsoregistret [in Swedish]. Stockholm: Socialstyrelsen 2016 Sep 12. Report no. 2016-9-32. Available from: https:\/\/www.socialstyrelsen.se\/contentassets\/82c7a6754ac545f49487b58738155a4d\/2016-9-32.pdf. Accessed Jun 27, 2025."},{"issue":"1","key":"19101_CR23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12903-019-0804-7","volume":"19","author":"R Ljung","year":"2019","unstructured":"Ljung R, Lundgren F, Appelquist M, et al. The Swedish dental health register - validation study of remaining and intact teeth. BMC Oral Health. 2019;19(1):116.","journal-title":"BMC Oral Health"},{"issue":"4","key":"19101_CR24","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10654-019-00511-8","volume":"34","author":"JF Ludvigsson","year":"2019","unstructured":"Ludvigsson JF, Svedberg P, Ol\u00e9n O, et al. The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research. Eur J Epidemiol. 2019;34(4):423\u201337.","journal-title":"Eur J Epidemiol"},{"key":"19101_CR25","unstructured":"Socialstyrelsen. Det statistiska registrets framst\u00e4llning och kvalitet \u2013 D\u00f6dsorsaksregistret [in Swedish]. Stockholm: Socialstyrelsen 2022 May 18. Report no. 2022-5-7909. Available from: https:\/\/www.socialstyrelsen.se\/contentassets\/ac8fdebe41114d6ba387b1a792f4c7d6\/2022-5-7909.pdf. Last accessed June 27, 2025."},{"issue":"3","key":"19101_CR26","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41416-021-01419-5","volume":"125","author":"S Gao","year":"2021","unstructured":"Gao S, Liu Y, Duan X, et al. Porphyromonas gingivalis infection exacerbates oesophageal cancer and promotes resistance to neoadjuvant chemotherapy. Br J Cancer. 2021;125(3):433\u201344.","journal-title":"Br J Cancer"},{"issue":"2","key":"19101_CR27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s13402-020-00573-x","volume":"44","author":"MF Chen","year":"2021","unstructured":"Chen MF, Lu MS, Hsieh CC, et al. Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma. Cell Oncol (Dordr). 2021;44(2):373\u201384.","journal-title":"Cell Oncol (Dordr)"},{"key":"19101_CR28","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1477-7525-8-126","volume":"8","author":"AE Gerritsen","year":"2010","unstructured":"Gerritsen AE, Allen PF, Witter DJ, et al. Tooth loss and oral health-related quality of life: a systematic review and meta-analysis. Health Qual Life Outcomes. 2010;8:126.","journal-title":"Health Qual Life Outcomes"},{"key":"19101_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bpg.2018.11.008","volume":"36\u201337","author":"SH Xie","year":"2018","unstructured":"Xie SH, Lagergren J. Risk factors for oesophageal cancer. Best Pract Res Clin Gastroenterol. 2018;36\u201337:3\u20138.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"9","key":"19101_CR30","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/bjs.9854","volume":"102","author":"L Backemar","year":"2015","unstructured":"Backemar L, Lagergren P, Johar A, et al. Impact of co-morbidity on mortality after oesophageal cancer surgery. Br J Surg. 2015;102(9):1097\u2013105.","journal-title":"Br J Surg"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19101-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19101-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19101-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T12:26:52Z","timestamp":1776256012000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19101-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["19101"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19101-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"EGV has received consultancy fees from Sanofi, unrelated to the current study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}